Opus Capital Group’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $309K | Hold |
|
|||||
|
2025
Q2 | $320K | Hold |
|
|||||
|
2025
Q1 | $298K | Hold |
|
|||||
|
2024
Q4 | $373K | Buy |
|
|||||
|
2024
Q3 | $186K | Hold |
|
|||||
|
2024
Q2 | $138K | Buy |
|
|||||
|
2024
Q1 | $155K | Hold |
|
|||||
|
2023
Q4 | $284K | Hold |
|
|||||
|
2023
Q3 | $200K | Buy |
|
|||||
|
2023
Q2 | $215K | Hold |
|
|||||
|
2023
Q1 | $227K | Hold |
|
|||||
|
2022
Q4 | $245K | Buy |
|
|||||
|
2022
Q3 | $170K | Hold |
|
|||||
|
2022
Q2 | $165K | Hold |
|
|||||
|
2022
Q1 | $203K | Hold |
|
|||||
|
2021
Q4 | $286K | Hold |
|
|||||
|
2021
Q3 | $296K | Buy |
|
|||||
|
2021
Q2 | $240K | Buy |
|
|||||
|
2021
Q1 | $150K | Hold |
|
|||||
|
2020
Q4 | $54K | Hold |
|
|||||
|
2020
Q3 | $46K | Buy |
|